159 related articles for article (PubMed ID: 12392802)
1. Heroin detoxification with buprenorphine on an inpatient psychiatric unit.
DiPaula BA; Schwartz R; Montoya ID; Barrett D; Tang C
J Subst Abuse Treat; 2002 Oct; 23(3):163-9. PubMed ID: 12392802
[TBL] [Abstract][Full Text] [Related]
2. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
3. Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients.
Ang-Lee K; Oreskovich MR; Saxon AJ; Jaffe C; Meredith C; Ellis ML; Malte CA; Knox PC
J Psychoactive Drugs; 2006 Dec; 38(4):505-12. PubMed ID: 17373566
[TBL] [Abstract][Full Text] [Related]
4. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study.
Tamaskar R; Parran TV; Heggi A; Brateanu A; Rabb M; Yu J
J Addict Dis; 2003; 22(4):5-12. PubMed ID: 14723474
[TBL] [Abstract][Full Text] [Related]
5. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence.
Hopper JA; Wu J; Martus W; Pierre JD
J Opioid Manag; 2005; 1(1):31-5. PubMed ID: 17315409
[TBL] [Abstract][Full Text] [Related]
7. The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients.
Welsh CJ; Suman M; Cohen A; Broyles L; Bennett M; Weintraub E
Am J Addict; 2002; 11(2):135-40. PubMed ID: 12028743
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts.
Jain K; Jain R; Dhawan A
J Opioid Manag; 2011; 7(1):11-20. PubMed ID: 21434580
[TBL] [Abstract][Full Text] [Related]
9. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
Ziedonis DM; Amass L; Steinberg M; Woody G; Krejci J; Annon JJ; Cohen AJ; Waite-O'Brien N; Stine SM; McCarty D; Reid MS; Brown LS; Maslansky R; Winhusen T; Babcock D; Brigham G; Muir J; Orr D; Buchan BJ; Horton T; Ling W
Drug Alcohol Depend; 2009 Jan; 99(1-3):28-36. PubMed ID: 18805656
[TBL] [Abstract][Full Text] [Related]
10. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone shortened opioid detoxification with buprenorphine.
Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
[TBL] [Abstract][Full Text] [Related]
12. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.
González-Saiz F; Lozano Rojas O; Trujols J; Alcaraz S; Siñol N; Pérez de Los Cobos J;
Drug Alcohol Depend; 2018 Feb; 183():127-133. PubMed ID: 29247974
[TBL] [Abstract][Full Text] [Related]
13. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG
J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan.
Nagano T; Kimoto S; Aso K; Komori T; Yamaguchi Y; Okamura K; Yamamoto N; Kishimoto T
Neuropsychopharmacol Rep; 2020 Dec; 40(4):376-382. PubMed ID: 33107693
[TBL] [Abstract][Full Text] [Related]
15. Heroin detoxification.
Favrat B; Besson J
JAMA; 2006 Feb; 295(8):885; author reply 886. PubMed ID: 16493096
[No Abstract] [Full Text] [Related]
16. Heroin detoxification.
Miller MM
JAMA; 2006 Feb; 295(8):885-6; author reply 886. PubMed ID: 16493095
[No Abstract] [Full Text] [Related]
17. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
18. Rapid heroin detoxification using a single high dose of buprenorphine.
Kutz I; Reznik V
J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
[TBL] [Abstract][Full Text] [Related]
20. Methods of detoxification and their role in treating patients with opioid dependence.
O'Connor PG
JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
